Community Academic Profiles–

Paul Heidenreich, MD

Back to Profile

Publication Details

  • Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.

    Heidenreich PA, Gubens MA, Fonarow GC, Konstam MA, Stevenson LW, Shekelle PG. J Am Coll Cardiol. 2004; 43 (6): 1019-26

    This study was designed to evaluate the cost-effectiveness of screening patients with a B-type natriuretic peptide (BNP) blood test to identify those with depressed left ventricular systolic function.

    PubMedID: 15028361

Stanford Medicine Resources:

Footer Links: